Spier CM - Search Results

1

Diffuse small cleaved-cell lymphoma: a heterogeneous disease with distinct immunobiologic subsets.

Leith CP, Spier CM, Grogan TM, Gonzales G, Rangel CS, Rybski JA, Matzner M, Miller TP. Leith CP, et al. Among authors: spier cm. J Clin Oncol. 1992 Aug;10(8):1259-65. doi: 10.1200/JCO.1992.10.8.1259. J Clin Oncol. 1992. PMID: 1634915

2

Burkitt's-like lymphoma of T-cell type.

Oliver JD, Grogan TM, Payne CM, Spier C, Richter LC, Rangel CS. Oliver JD, et al. Among authors: spier c. Mod Pathol. 1988 Jan;1(1):15-22. Mod Pathol. 1988. PMID: 3266334

3

Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: relationship to HLA expression and host immunocompetence.

List AF, Spier CM, Miller TP, Grogan TM. List AF, et al. Among authors: spier cm. Leukemia. 1993 Mar;7(3):398-403. Leukemia. 1993. PMID: 7680400

4

The presence of bcl-1 and bcl-2 gene rearrangements in diffuse small cleaved-cell lymphoma. A disease with diverse molecular and immunophenotypic findings.

Leith CP, Willman CL, Spier CM, Miller TP, Grogan TM. Leith CP, et al. Among authors: spier cm. Diagn Mol Pathol. 1994 Sep;3(3):178-83. doi: 10.1097/00019606-199409000-00007. Diagn Mol Pathol. 1994. PMID: 7981893

5

Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial.

Miller TP, Grogan TM, Dahlberg S, Spier CM, Braziel RM, Banks PM, Foucar K, Kjeldsberg CR, Levy N, Nathwani BN, et al. Miller TP, et al. Among authors: spier cm. Blood. 1994 Mar 15;83(6):1460-6. Blood. 1994. PMID: 8123837 Free article. Clinical Trial.

6

P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil.

Miller TP, Grogan TM, Dalton WS, Spier CM, Scheper RJ, Salmon SE. Miller TP, et al. Among authors: spier cm. J Clin Oncol. 1991 Jan;9(1):17-24. doi: 10.1200/JCO.1991.9.1.17. J Clin Oncol. 1991. PMID: 1670642

7

Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphoma.

Slymen DJ, Miller TP, Lippman SM, Spier CM, Kerrigan DP, Rybski JA, Rangel CS, Richter LC, Grogan TM. Slymen DJ, et al. Among authors: spier cm. J Clin Oncol. 1990 Jun;8(6):986-93. doi: 10.1200/JCO.1990.8.6.986. J Clin Oncol. 1990. PMID: 2140855

8

Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course.

Lippman SM, Spier CM, Miller TP, Slymen DJ, Rybski JA, Grogan TM. Lippman SM, et al. Among authors: spier cm. Mod Pathol. 1990 May;3(3):361-7. Mod Pathol. 1990. PMID: 2194216

9

The aberrancy of immunophenotype and immunoglobulin status as indicators of prognosis in B cell diffuse large cell lymphoma.

Spier CM, Grogan TM, Lippman SM, Slymen DJ, Rybski JA, Miller TP. Spier CM, et al. Am J Pathol. 1988 Oct;133(1):118-26. Am J Pathol. 1988. PMID: 3140668 Free PMC article.

10

Lennert's lymphoma. A clinicopathologic study with emphasis on phenotype and its relationship to survival.

Spier CM, Lippman SM, Miller TP, Grogan TM. Spier CM, et al. Cancer. 1988 Feb 1;61(3):517-24. doi: 10.1002/1097-0142(19880201)61:3<517::aid-cncr2820610317>3.0.co;2-1. Cancer. 1988. PMID: 3257404

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters